Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Research

• Publication date

  2002-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12019178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AJCC Cancer Staging Manual

  2002cited by this paper
• Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma

  2001cited by this paper
• Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.

  2001cited by this paper
• Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.

  2000cited by this paper
• Contemporary approach to the classification of renal epithelial tumors.

  2000cited by this paper
• Hypoxia-inducible Factor-1α Is a Positive Factor in Solid Tumor Growth

  2000cited by this paper
• Candidate genes for the hypoxic tumor phenotype.

  2000influential reference
• Expression of hypoxia‐inducible factor 1α in brain tumors

  2000cited by this paper
• Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling

  2000cited by this paper
• A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning

  2000cited by this paper
• The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages

  2000cited by this paper
• Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression.

  2000cited by this paper
• Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression

  2000cited by this paper
• Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein

  2000cited by this paper
• Suppression of tumor growth through disruption of hypoxia-inducible transcription

  2000cited by this paper
• Mechanism of regulation of the hypoxia‐inducible factor‐1α by the von Hippel‐Lindau tumor suppressor protein

  2000cited by this paper
• The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages.

  2000cited by this paper
• Contemporary approach to the classification of renal epithelial tumors.

  2000cited by this paper
• Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex.

  2000cited by this paper
• Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function

  2000cited by this paper
• Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

  2000cited by this paper
• Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein*

  2000cited by this paper
• Long polymerase chain reaction in detection of germline deletions in the von Hippel-Lindau tumour suppressor gene

  1999cited by this paper
• The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

  1999influential reference
• Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis

  1998cited by this paper
• Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway

  1998cited by this paper
• Up-Regulation of Vascular Endothelial Growth Factor in Stromal Cells of Hemangioblastomas Is Correlated with Up-Regulation of the Transcription Factor HRF/HIF-2α

  1998cited by this paper
• Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha.

  1998cited by this paper
• Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2alpha.

  1998cited by this paper
• Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.

  1998cited by this paper
• Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

  1997cited by this paper
• Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells.

  1997influential reference
• Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.

  1997cited by this paper
• Transcriptional Regulation of the Rat Vascular Endothelial Growth Factor Gene by Hypoxia (*)

  1995cited by this paper
• Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

  1995cited by this paper
• Improved RNase protection assay for quantifying LDL-receptor mRNA; estimation of analytical imprecision and biological variance in peripheral blood mononuclear cells.

  1995cited by this paper
• Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.

  1995influential reference
• Hypoxia and Mitochondrial Inhibitors Regulate Expression of Glucose Transporter-1 via Distinct Cis-acting Sequences (*)

  1995cited by this paper
• Mutations of the VHL tumour suppressor gene in renal carcinoma

  1994cited by this paper
• Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

  1994influential reference

• ZNF395 Is a Hypoxia-Responsive Regulator of Mitochondrial Glutaminolysis in Clear Cell Renal Cell Carcinoma.

  2026cites this paper
• Dietary patterns, polygenic risk, and kidney cancer incidence: a UK Biobank cohort study

  2025cites this paper
• Genomic and Epigenomic Plasticity in the Hypoxic Environment

  2025cites this paper
• The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy.

  2025cites this paper
• Hypoxia reduces SLC27A5 to promote hepatocellular carcinoma proliferation by repressing HNF4A.

  2025cites this paper
• REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity.

  2025cites this paper
• HIF2α inhibits glutaminase clustering in mitochondria to sustain growth of clear cell renal cell carcinoma

  2025cites this paper
• Late-Onset Metastasis of Renal Cell Carcinoma: A Rare Case of Sinonasal Malignancy Post-Nephrectomy

  2024cites this paper
• Low nuclear expression of HIF‐hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence‐free survival in clear cell renal cell carcinoma

  2024cites this paper
• HIF2α inhibits glutaminase clustering in mitochondria to sustain growth of clear cell Renal Cell Carcinoma

  2024cites this paper
• Understanding Factors that Influence Prognosis and Response to Therapy in Clear Cell Renal Cell Carcinoma.

  2024cites this paper
• Updated perspective of EPAS1 and the role in pulmonary hypertension

  2023cites this paper
• Neoadjuvant Systemic Therapy in Localized and Locally Advanced Renal Cell Carcinoma

  2022cites this paper
• Expression levels of sonic hedgehog pathway genes and their targets are upregulated in early clear cell renal cell carcinoma

  2022cites this paper
• HIF2 inactivation and tumor suppression with a tumor-directed RNA-silencing drug in mice and humans.

  2022cites this paper
• Hypoxia-related prognostic model in bladder urothelial reflects immune cell infiltration.

  2021cites this paper
• Hypoxia and cancer related pathology.

  2020cites this paper
• Choosing The Right Animal Model for Renal Cancer Research☆

  2020cites this paper
• Combination drug regimens for metastatic clear cell renal cell carcinoma

  2020cites this paper
• Clinicopathological implications of the expression of vascular endothelial growth factor and programmed cell death ligand 1 in clear cell renal cell carcinoma.

  2020cites this paper
• Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue‐based research

  2020cites this paper
• Frequency of Kidney Cancer in Nephrectomy Specimens in Different Hospitals in Dhaka Bangladesh – a Retrospective Study

  2020cites this paper
• wPrognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear-cell renal cell carcinoma treated with sunitinib as first-line treatment

  2019influential citation
• Endogenous reporter systems for high-throughput functional screening in clear cell renal cell carcinoma

  2019cites this paper
• A Novel Prognostic Criteria and Targeted Therapy in Sarcomatoid Variant of Chromophobic Renal Cell Carcinoma

  2019cites this paper
• Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma

  2019cites this paper
• Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?

  2019cites this paper
• Petra Miikkulainen: NEW FUNCTIONS FOR THE CELLULAR OXYGEN SENSOR PHD3 IN CLEAR CELL RENAL CELL CARCINOMA

  2018cites this paper
• Sinonasal Metastatic Renal Cell Carcinoma: A Report of Two Cases with Varied Presentation and a Review of Literature

  2018cites this paper
• Renal cell carcinoma: new insights and challenges for a clinician scientist.

  2017cites this paper
• Network-Based Approaches To Identify The Impacted Genes And Active Interactions

  2017cites this paper
• Carcinogenesis of renal cell carcinoma reflected in HLA ligands: A novel approach for synergistic peptide vaccination design

  2016cites this paper
• HIF-1α activates hypoxia-induced PFKFB4 expression in human bladder cancer cells.

  2016cites this paper
• ISSN 2320-5407 International Journal of Advanced Research (2016), Volume 4, Issue 1, 706- 715

  2016cites this paper
• The Evolving Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in Renal Cell Carcinoma

  2016cites this paper
• Tuberous sclerosis complex protein 1 expression is affected by VHL Gene alterations and HIF-1α production in sporadic clear-cell renal cell carcinoma.

  2016cites this paper
• Hypoxia inducible factor-1 alpha and multiple myeloma.

  2016cites this paper
• Dicer suppresses the malignant phenotype in VHL-deficient clear cell renal cell carcinoma by inhibiting HIF-2α

  2016cites this paper
• Identification of a hypoxia-regulated miRNA signature in bladder cancer and a role for miR-145 in hypoxia-dependent apoptosis

  2015cites this paper
• Efficacy and Toxicity of Sunitinib in Egyptian Patients with Metastatic Renal Cell Carcinoma

  2015cites this paper
• Assessment of oxidative damage to DNA, transcriptional expression of key genes, lipid peroxidation and histopathological changes in carp Cyprinus carpio L. following exposure to chronic hypoxic and subsequent recovery in normoxic conditions.

  2015cites this paper
• Efficacy and toxicity of sunitinib in metastatic renal cell carcinoma patients in Egypt.

  2015cites this paper
• Hypoxia-induced SUMOylation of E3 ligase HAF determines specific activation of HIF2 in clear-cell renal cell carcinoma.

  2015cites this paper
• Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma

  2015cites this paper
• Contributions à l'étude de la réponse moléculaire à l'hypoxie : Modélisation mathématique et expérimentations sur cellules FUCCI

  2015cites this paper
• Hypoxia-inducible factor-2α (HIF-2α) mediates the effects of hypoxia on the promotion of HeLa cell viability, colony formation, and invasion capacity in vitro.

  2015influential citation
• Correlation between BOLD-MRI and HIF expression level in renal carcinoma.

  2015cites this paper
• Biological Effects After Discontinuation of VEGFR Inhibitors in Metastatic Renal Cell Cancer.

  2015cites this paper
• A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.

  2014cites this paper
• NADPH oxidase NOX4 supports renal tumorigenesis by promoting the expression and nuclear accumulation of HIF2α.

  2014cites this paper
• Novel mutations and role of the LKB1 gene as a tumor suppressor in renal cell carcinoma

  2014cites this paper
• Role of Compartmentalization on HiF-1α Degradation Dynamics during Changing Oxygen Conditions: A Computational Approach

  2014cites this paper
• Inhibition of Hypoxia Inducible Factor 1α by siRNA‐Induced Apoptosis in Human Retinoblastoma Cells

  2014cites this paper
• Management of metastatic kidney cancer in the era of personalized medicine

  2014cites this paper
• MicroRNAs in the Development and Progression of Kidney Cancer

  2014cites this paper
• RETRACTED CHAPTER: Molecular Testing in Adult Kidney Tumors

  2014cites this paper
• Molecular and Cellular Pathobiology NADPH Oxidase NOX 4 Supports Renal Tumorigenesis by Promoting the Expression and Nuclear Accumulation of HIF 2 a

  2014cites this paper
• Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma

  2014cites this paper
• Improving outcomes in metastatic clear cell renal cell carcinoma by sequencing therapy.

  2014cites this paper
• Hypoxia regulates the sperm associated antigen 4 (SPAG4) via HIF, which is expressed in renal clear cell carcinoma and promotes migration and invasion in vitro

  2014cites this paper
• Intermittent Hypoxia: Mechanistic Pathways Influencing Cancer

  2014cites this paper
• From THE DEPARTMENT OF MICROBIOLOGY, TUMOR AND CELL BIOLOY Karolinska Institutet, Stockholm, Sweden ROLE OF ANGIOGENESIS IN CANCER INVASION AND METASTASIS

  2013cites this paper
• abnormalities but not tumors Chuvash polycythemia VHL mutation with thrombosis and vascular Congenital disorder of oxygen sensing: association of the homozygous

  2013cites this paper
• Phospholipid Composition and Electric Charge in Healthy and Cancerous Parts of Human Kidneys

  2013cites this paper
• Carcinoma Associated with Loss of in Renal Cell Α Up-regulation of Hypoxia-inducible Factor 2 Updated Version Cited Articles Citing Articles E-mail Alerts Up-regulation of Hypoxia-inducible Factor 2␣ in Renal Cell Carcinoma Associated with Loss of Tsc-2 Tumor Suppressor Gene 1

  2013cites this paper
• Analyses of Potential Predictive Markers and Survival Data for a Response to Sunitinib in Patients with Metastatic Renal Cell Carcinoma

  2013cites this paper
• Role of Hypoxia-inducible Factor in Kidney Cancer

  2013influential citation
• Novel Targeting of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin in Renal Cell Carcinoma

  2013cites this paper
• Arsenic induces the expressions of angiogenesis-related factors through PI3K and MAPK pathways in SV-HUC-1 human uroepithelial cells.

  2013influential citation
• Kidney Cancer Genomics: Paving the Road to a New Paradigm of Personalized Medicine

  2013cites this paper
• Induction of erythropoietin increases the cell proliferation rate in a hypoxia-inducible factor-1-dependent and -independent manner in renal cell carcinoma cell lines

  2013cites this paper
• Renal Tubular HIF-2α Expression Requires VHL Inactivation and Causes Fibrosis and Cysts

  2012cites this paper
• Tyrosine kinase expression profile in clear cell renal cell carcinoma

  2012cites this paper
• The future of adjuvant therapy for renal cell carcinoma

  2012cites this paper
• Renal cancer: oxygen meets metabolism.

  2012cites this paper
• Angiogenesis and expression of vascular endothelial growth factor, tumour necrosis factor-α and hypoxia inducible factor-1α in canine renal cell carcinoma.

  2012cites this paper
• Malignant Renal Tumors

  2012cites this paper
• The effects of nrf2 on tumor angiogenesis: a review of the possible mechanisms of action.

  2012cites this paper
• Anthracycline Inhibits Recruitment of Hypoxia-inducible Transcription Factors and Suppresses Tumor Cell Migration and Cardiac Angiogenic Response in the Host*

  2012cites this paper
• ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell Carcinoma

  2012cites this paper
• Safety and efficacy of temsirolimus in heavily pretreated patients with metastatic renal cell carcinoma

  2012cites this paper
• Tumor microvasculature with endothelial fenestrations in VHL null clear cell renal cell carcinomas as a potent target of anti‐angiogenic therapy

  2012cites this paper
• Role of GAL3ST1 in Renal Cell Carcinoma

  2012cites this paper
• Role of the SDF-1/CXCR4/eNOS Signaling Pathway in Chronic Kidney Disease

  2012influential citation
• Pseudohypoxia, Mitochondrial Mutations, the Warburg Effect, and Cancer.

  2012cites this paper
• Future directions in renal cell carcinoma: 2011 and beyond.

  2011cites this paper
• VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin

  2011cites this paper
• Expression of hypoxia inducible factor-1α and 2α in conventional renal cell carcinoma with or without sarcomatoid differentiation.

  2011cites this paper
• Clinical and molecular prognostic factors in renal cell carcinoma: what we know so far.

  2011cites this paper
• Chapter 54 – Kidney and Ureteral Carcinoma

  2011cites this paper
• Pazopanib in the treatment of renal cell carcinoma

  2011cites this paper
• The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma

  2011cites this paper
• Challenges and Successes in Developing Effective Anti-angiogenic Agents

  2011cites this paper
• Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer

  2011cites this paper
• Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma

  2011cites this paper
• The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.

  2010cites this paper
• Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3.

  2010cites this paper
• Clinical Applications of Kinase Inhibitors in Solid Tumors

  2010cites this paper
• Everolimus: Emerging Evidence of its Therapeutic Impact in Patients with Advanced Renal Cell Carcinoma

  2010cites this paper
• Analysis of succinate dehydrogenase subunit B gene alterations in gastric cancers

  2010cites this paper